GPAT vs IBAC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

GPAT

56.9
AI Score
VS
IBAC Wins

IBAC

63.5
AI Score

Investment Advisor Scores

GPAT

57score
Recommendation
HOLD

IBAC

64score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GPAT IBAC Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth -86.2% -10.4% IBAC
Tradestie Score 56.9/100 63.5/100 IBAC
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GPAT 1M: +0.3% · 3M: — IBAC 1M: -0.1% · 3M: +0.7%

Current Technical Phase

GPAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.5 · Price: $10.87

IBAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.2 · Price: $10.79

Fundamentals Snapshot

Metric GPAT IBAC
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 44.5 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS 0.25 -0.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBAC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.